HOME >> BIOLOGY >> NEWS
Small RNA surmounts large cancer problem

Many potentially effective cancer treatments are undone by the onset of resistance to the treatment. In order to circumvent this problem, D. Gary Gilliland and colleagues, of Brigham and Women's Hospital, have developed a strategy using the latest technologies involving small interfering RNA to enhance cancer treatment even in a situation where drug resistance has developed. Small interfering RNAs work by inhibiting the expression of specific genes that have a matching complimentary sequence. The authors theorized that this type of RNA treatment might boost the effectiveness of anti-cancer treatments. They tested their theory in a form of leukemia that is caused when two genes fuse to form an unregulated gene that transforms normal cells into cancer cells, a gene called TEL-PDGFbetaR. This form of leukemia is generally treated with a commonly used anti-cancer drug called imatinib, which is a small molecule protein inhibitor that blocks the activity of the protein produced from the fusion gene TEL-PDGFbetaR. Gilliland and colleagues created a small inhibitory RNA specific to the TEL-PDGFbetaR fusion gene, and found that its expression did indeed exclusively reduce the expression of the oncogenic TEL-PDGFbetaR by 90%. While this alone was not sufficient to kill the cancer cells, this treatment enhanced the ability of imatinib to kill these cancer cells. Further, when they tested this strategy with imatinib-resistant cells, the inhibitory RNA was still able to reduce this gene's expression, and enhanced the activity of another small molecule inhibitor. This study demonstrates that small inhibitory RNA treatment may be an extremely useful adjunct to cancer treatments, and can also aid in overcoming the common problem of drug resistance when used in conjunction with anticancer agents.


'"/>

Contact: Laurie Goodman
press_releases@the-jci.org
212-342-4159
Journal of Clinical Investigation
15-Jun-2004


Page: 1

Related biology news :

1. Small, Smac-like molecule encourages death of cancer cells
2. Small animal imaging gives cancer clues
3. Small, cold, & hungry: Ultra-small microbes from 120,000-year-old glacier ice sample
4. Small trial shows daclizumab add-on therapy improves MS outcome
5. Small gene changes in some leukemia patients may explain varying responses to chemotherapy
6. Small amounts of alcohol or anesthetics may damage the developing brain
7. Smallpox in 50-year-old tissues detected by integrated diagnostics approach
8. Small-molecule inhibitors of anthrax lethal factor identified
9. Smallpox in Europe selected for genetic mutation that confers resistance to HIV infection
10. Small-molecule inhibitors of botulinum neurotoxin identified
11. Smallest whirlpools can pack stunningly strong force

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/4/2019)... ... April 02, 2019 , ... ... company, will present results demonstrating that RNA genetic testing (RGT), as a supplement ... study, awarded as a Top Rated poster, is one of 13 presentations at ...
(Date:4/1/2019)... SAN FRANCISCO (PRWEB) , ... April 01, 2019 ... ... entitled “Method and System for Characterizing Skin Related Conditions” by the US Patent ... 21, 2014. The patent is an invention by uBiome collaborators Dr. Zachary ...
(Date:3/29/2019)... ... March 28, 2019 , ... In the development of biosimilars, ... a path for this task. Despite this uncertainty, several manufacturers have been successful and ... the first part of this webinar, learn how analytical similarity is achieved in biosimilars ...
Breaking Biology News(10 mins):
(Date:4/4/2019)... ... April 02, 2019 , ... Biomeme, Inc. , ... it’s latest field-ready solution for performing PCR, RT-PCR, qPCR, and Isothermal tests called ... to Rosland Franklin, an English chemist and X-ray crystallographer who made significant contributions ...
(Date:3/27/2019)... ... , ... Lachman is sponsoring the event on April 1-4, where they will ... executive team on site will be available to discuss strategies and tactics to support ... year. , Executives from Lachman participating at this year’s conference include Fran Zipp, President ...
(Date:3/19/2019)... Calif. (PRWEB) , ... March 19, 2019 , ... Bogey was nine years old when ... arthritis in his left hip. These ailments caused Bogey to experience problems with his ... vehicles, up stairs, and onto his special spot on the couch. , His owners, devastated ...
(Date:3/18/2019)... ... March 18, 2019 , ... For more than 15 years, USDM Life ... life science companies to easily comply with FDA 21 CFR Part 11 and EMA ... managed service delivering end-to-end GxP compliance from vendor audit through ongoing validation maintenance, including ...
Breaking Biology Technology:
Cached News: